Adults also mainly have the inattentive type, meaning they are more likely to procrastinate and have difficulty organizing tasks. As the name suggests, the combined type of ADHD presents as a mix ...

There is an urgent need for biomarkers for the early detection of ovarian cancer (OC). The purpose of this study was to assess whether changes in serum levels of lecithin-cholesterol ...

There are three types of ADHD: impulsive/hyperactive type ADHD, inattentive type ADHD, and combined type ADHD, which involves symptoms of both the first two types. People with impulsive ...

The third type has some symptoms from each of the other two and is called the combined type. Children with ADHD often have trouble functioning at home and in school and can have difficulty making ...

Curative chemoradiation for low rectal cancer: Primary clinical outcomes from a multicenter phase II trial. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting II. This abstract does ...

The traditional system of diagnosis has particularly failed those with combined type ADHD, where symptoms are less overt than the disruptive, hyperactive and easily distracted behaviors most often ...

Table 2 Concomitant Antihypertensive Therapies Received at Baseline and during the Double-Blind Period among Patients with Type 2 Diabetes ... was higher with the combined drugs than with placebo ...

The work is published in a paper titled, “A Combined Risk Score Enhances Prediction of Type 1 Diabetes Among Susceptible Children,” published in Nature Medicine. The team developed a combined ...

SGLT2 inhibitors cut the risk for adverse CV outcomes and CKD for adults with type 2 diabetes using a GLP-1. Combined SGLT2 and GLP-1 therapy may provide additional benefits than either medication ...

Use of compounded HT and estrogen alone for menopause symptoms were associated with increased risk for type 2 diabetes. Combined estrogen plus progestin from the manufacturer was not linked to ...

TST001 (a high affinity humanized anti-claudin18.2 monoclonal antibody) in combination with nivolumab plus capecitabine and oxaliplatin as first-line or with nivolumab as late-line treatment in ...